Advertisement

Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011

Published:August 10, 2015DOI:https://doi.org/10.1016/j.jamda.2015.06.020

      Abstract

      Objective

      Although nursing home (NH) residents make up a large and growing proportion of Americans with diabetes mellitus, little is known about how glucose-lowering medications are used in this population. We sought to examine glucose-lowering medication use in Veterans Affairs (VA) NH residents with diabetes between 2005 and 2011.

      Research Design and Methods

      Retrospective cohort study, using linked laboratory, pharmacy, administrative, and NH Minimum Dataset (MDS) 2.0 databases in 123 VA NHs. A total of 9431 long-stay (>90 days) VA NH residents older than 65 followed for 52,313 person-quarters. We identified receipt of glucose-lowering medications, including insulin, metformin, sulfonylureas, thiazolidinediones, and others (alpha-glucosidase inhibitors, meglitinides, glucagonlike peptide-1 analogs, dipeptidyl peptidase-4 inhibitors and amylin analogs) per quarter.

      Results

      The rates of sulfonylurea use in long-stay NH residents dropped dramatically from 24% in 2005 to 12% in 2011 (P < .001), driven in large part by the dramatic decrease in glyburide use (10% to 2%, P < .001). There was sharp drop in thiazolidinedione use in 2007 (4% to <1%, P < .001). Metformin use was stable, ranging between 7% and 9% (P = .24). Insulin use increased slightly from 30% to 32% (P < .001). Use of other classes of glucose-lowering medications was stable (P = .22) and low, remaining below 1.3%.

      Conclusions and Relevance

      Between 2005 and 2011, there were dramatic declines in use of sulfonylureas and thiazolidinediones in VA NH residents, suggesting that prescribing practices can be quickly changed in this setting.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zhang X.
        • Decker F.H.
        • Luo H.
        • et al.
        Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995–2004.
        J Am Geriatr Soc. 2010; 58: 724-730
        • Resnick H.E.
        • Heineman J.
        • Stone R.
        • Shorr R.I.
        Diabetes in U.S. nursing homes, 2004.
        Diabetes Care. 2008; 31: 287-288
        • Boyle J.P.
        • Thompson T.J.
        • Gregg E.W.
        • et al.
        Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence.
        Popul Health Metr. 2010; 8: 29
        • Huang E.S.
        • Laiteerapong N.
        • Liu J.Y.
        • et al.
        Rates of complications and mortality in older patients with diabetes mellitus: The diabetes and aging study.
        JAMA Intern Med. 2014; 174: 251-258
        • Zarowitz B.J.
        • Tangalos E.G.
        • Hollenack K.
        • O'Shea T.
        The application of evidence-based principles of care in older persons (issue 3): Management of diabetes mellitus.
        J Am Med Dir Assoc. 2006; 7: 234-240
        • Feldman S.M.
        • Rosen R.
        • DeStasio J.
        Status of diabetes management in the nursing home setting in 2008: A retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management.
        J Am Med Dir Assoc. 2009; 10: 354-360
        • American Diabetes Association
        Standards of medical care in diabetes—2007.
        Diabetes Care. 2007; 30: S4-S41
        • Woodcock J.
        • Sharfstein J.M.
        • Hamburg M.
        Regulatory action on rosiglitazone by the U.S. Food and Drug Administration.
        N Engl J Med. 2010; 363: 1489-1491
        • Nissen S.E.
        • Wolski K.
        Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
        N Engl J Med. 2007; 356: 2457-2471
        • Tanne J.H.
        FDA places “black box” warning on antidiabetes drugs.
        BMJ. 2007; 334: 1237
        • Gerstein H.C.
        • Miller M.E.
        • Byington R.P.
        • et al.
        • Action to Control Cardiovascular Risk in Diabetes Study Group
        Effects of intensive glucose lowering in type 2 diabetes.
        N Engl J Med. 2008; 358: 2545-2559
        • Lee S.J.
        • Eng C.
        Goals of glycemic control in frail older patients with diabetes.
        JAMA. 2011; 305: 1350-1351
        • Inzucchi S.E.
        • Bergenstal R.M.
        • Buse J.B.
        • et al.
        Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
        Diabetes Care. 2012; 35: 1364-1379
        • Kirkman M.S.
        • Briscoe V.J.
        • Clark N.
        • et al.
        Diabetes in older adults.
        Diabetes Care. 2012; 35: 2650-2664
        • American Diabetes Association
        Standards of medical care in diabetes—2014.
        Diabetes Care. 2014; 37: S14-S80
        • Smith M.W.
        • Joseph G.J.
        Pharmacy data in the VA health care system.
        Med Care Res Rev. 2003; 60: 92S-123S
        • Dellefield M.E.
        The work of the RN Minimum Data Set coordinator in its organizational context.
        Res Gerontol Nurs. 2008; 1: 42-51
        • Schafer J.L.
        Multiple imputation: A primer.
        Stat Methods Med Res. 1999; 8: 3-15
        • White I.R.
        • Royston P.
        • Wood A.M.
        Multiple imputation using chained equations: Issues and guidance for practice.
        Stat Med. 2011; 30: 377-399
        • Morris J.N.
        • Fries B.E.
        • Morris S.A.
        Scaling ADLs within the MDS.
        J Gerontol A Biol Sci Med Sci. 1999; 54: M546-M553
        • Kurella Tamura M.
        • Covinsky K.E.
        • Chertow G.M.
        • et al.
        Functional status of elderly adults before and after initiation of dialysis.
        N Engl J Med. 2009; 361: 1539-1547
        • Desai N.R.
        • Shrank W.H.
        • Fischer M.A.
        • et al.
        Patterns of medication initiation in newly diagnosed diabetes mellitus: Quality and cost implications.
        Am J Med. 2012; 125: 302.e1-302.e7
        • American Geriatrics Society Beers Criteria Update Expert Panel
        American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.
        J Am Geriatr Soc. 2012; 60: 616-631
        • van Staa T.
        • Abenhaim L.
        • Monette J.
        Rates of hypoglycemia in users of sulfonylureas.
        J Clin Epidemiol. 1997; 50: 735-741
        • Shorr R.I.
        • Ray W.A.
        • Daugherty J.R.
        • Griffin M.R.
        Individual sulfonylureas and serious hypoglycemia in older people.
        J Am Geriatr Soc. 1996; 44: 751-755
        • Nathan D.M.
        • Buse J.B.
        • Davidson M.B.
        • et al.
        Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
        Diabetes Care. 2006; 29: 1963-1972
        • Nathan D.M.
        • Buse J.B.
        • Davidson M.B.
        • et al.
        Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
        Diabetes Care. 2009; 32: 193-203
        • Aspinall S.L.
        • Zhao X.
        • Good C.B.
        • et al.
        Intervention to decrease glyburide use in elderly patients with renal insufficiency.
        Am J Geriatr Pharmacother. 2011; 9: 58-68
        • Miller M.
        • Knatterud G.L.
        • Hawkins B.S.
        • Newberry Jr., W.B.
        A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide.
        Diabetes. 1976; 25: 1129-1153
        • Garratt K.N.
        • Brady P.A.
        • Hassinger N.L.
        • et al.
        Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.
        J Am Coll Cardiol. 1999; 33: 119-124
        • Simpson S.H.
        • Majumdar S.R.
        • Tsuyuki R.T.
        • et al.
        Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: A population-based cohort study.
        CMAJ. 2006; 174: 169-174
        • Schramm T.K.
        • Gislason G.H.
        • Vaag A.
        • et al.
        Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study.
        Eur Heart J. 2011; 32: 1900-1908
        • Garber A.J.
        • Abrahamson M.J.
        • Barzilay J.I.
        • et al.
        American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement—executive summary.
        Endocr Pract. 2013; 19: 536-557
        • Gionfriddo M.R.
        • McCoy R.G.
        • Lipska K.J.
        The 2013 American Association of Clinical Endocrinologists' diabetes mellitus management recommendations: Improvements needed.
        JAMA Intern Med. 2014; 174: 179-180
        • Hayward R.A.
        • Kent D.M.
        6 EZ steps to improving your performance: (or how to make P4P pay 4U!).
        JAMA. 2008; 300: 255-256
        • Li C.
        • Ford E.S.
        • Zhao G.
        • et al.
        Trends of insulin use among US adults with type 2 diabetes: The Behavioral Risk Factor Surveillance System, 1995–2007.
        J Diabet Complications. 2012; 26: 17-22
      1. Age-Adjusted Percentage of Adults with Diabetes Using Diabetes Medication, by Type of Medication, United States, 1997-2011. Nov 19, 2013. Available at: http://www.cdc.gov/diabetes/statistics/meduse/fig2.htm. Accessed June 24, 2015